Home / Resources / The Annual Clinical Trials Roundup, 2025 Edition: Innovation, Regulation, and Preservation
WHITE PAPER | OCT 1, 2025

The Annual Clinical Trials Roundup, 2025 Edition: Innovation, Regulation, and Preservation

Citeline’s Annual Clinical Trials Roundup 2025 Edition delivers a detailed analysis of 10,503 Phase I–III clinical trials initiated in 2024, revealing a 5.5% increase in trial starts and a 3.6% rise in industry-sponsored studies. After the rebound of 2023, this steady growth signals continued recovery across the global R&D landscape.

Inside, experts highlight where trial activity is accelerating, which therapeutic areas are driving innovation, and how regulatory and design trends are shaping the next wave of research.

If you’re planning or benchmarking trials in 2025, this report provides the data and context you need to make confident decisions.

Download the white paper for full data breakdown.

PDF preview of The Annual Clinical Trials Roundup 2025 Edition white paper available for download.
Citeline may contact you about relevant products, services, and content. To opt out of these communications or to manage what you receive, please visit our Preference Center.

Your information will be used in accordance with our Privacy notice.
Related products
Professional using a laptop device to access Trialtrove for trial insights and strategy.
Trialtrove
The go-to resource for informing clinical trial strategy, design and execution
Digital map showcasing the reach of Sitetrove, providing data from trial sites across the globe.
Sitetrove
The industry-leading suite of global clinical trial investigator and site intelligence
Healthcare professional monitoring and analyzing R and D trends.
Pharmaprojects
The industry standard for tracking and analyzing the global drug R&D landscape

Related resources

A healthcare professional reviews digital documents with checklists while working on a laptop.
AUG 21, 2025
Clinical

ICH E6(R3): 10 FAQ on What Changed & What It Means for Your Trials (Citeline Edition)

The updated Good Clinical Practice (GCP) guideline redefines quality, oversight, and transparency in trials. Find out what’s changed — and how Citeline can help you comply.

Claire Riches and Dan Chancellor
JUL 24, 2025
Article
Clinical

Shifting Landscapes and Technologies: The State of Biotech (So Far) in 2025

Citeline and Norstella experts discuss the biotech funding crunch, the need for competitive intelligence, the value of AI and RWD, and more.

A man pointing at a screen with a background of charts
JUN 06, 2025
White paper
Clinical

Annual Completed Clinical Trials Report: Finding Stable Ground in an Ever-evolving Industry Landscape

Citeline’s annual review of trends in clinical trials completed in 2024, based on Trialtrove data: top therapeutic areas, industry-sponsored trials, top five diseases, and more.

View all